Navigation Links
Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
Date:2/20/2008

LANSING, Mich., Feb. 20 /PRNewswire-USNewswire/ --

Background: In August 2007 the U.S. Department of Health and Human Services, Office of Human Research Protection (OHRP) expressed the belief that the MHA Keystone Center for Patient Safety & Quality Intensive Care Unit (ICU) collaborative was human subjects research and not quality improvement. As a result, the collaborative required review by the Institutional Review Board (IRB) at each participating hospital.

In light of OHRP's determination, the MHA Keystone Center worked with the participating hospitals to meet the requirements of human subjects research, including IRB review, while at the same time questioning the ruling. On Feb. 14, 2008, the OHRP overturned its previous ruling regarding the ICU collaborative.

The following statement is from Spencer Johnson, president of the Michigan Health & Hospital Association (MHA):

"In light of the recent OHRP ruling, the MHA is delighted to be moving forward with the lifesaving work of the MHA Keystone: ICU collaborative. The final ruling reached by the OHRP falls in step with the MHA's original assertion that the work of the MHA Keystone: ICU collaborative represented quality improvement, as opposed to human subjects research.

"During the past months, the MHA Keystone Center for Patient Safety & Quality and its expert partner, Johns Hopkins University, worked with the OHRP to clarify the definitions of quality improvement and human subjects research and ensure compliance with all state and federal patient safety regulations.

"We believe the oversight role of the OHRP is vital in assuring that patients' needs are served. At the same time, we are hopeful that this experience will create an environment for dialogue to better support quality improvement activities without overly burdensome research oversight.

"The MHA Keystone Center is fully committed to improving quality patient care in all Michigan hospitals and is proud of its role as a pioneer in patient safety and quality improvement. We look forward to the continued success of this collaborative and our other nation-leading patient safety advances."


'/>"/>
SOURCE Michigan Health & Hospital Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
2. Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
3. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
4. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
5. Superbug Outbreak Calls for Immediate Increased Attention on Infection Control
6. Hospital to Hold MRSA Briefing for Media and Community Leaders
7. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
8. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
9. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
10. Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
11. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Dec. 2, 2016   CytoSorbents Corporation (NASDAQ: ... its European Union approved CytoSorb ® cytokine adsorber ... patients worldwide, announced that Dr. Phillip Chan , ... Annual LD Micro Main Event investor conference held ... the Luxe Sunset Boulevard Hotel in Los ...
(Date:12/2/2016)...  Today, Simpson Healthcare Executives, a global leader in ... as winners of multiple awards at the 2016 MarCom ... PLATINUM level, Blue Zones Menu at the GOLD Level, ... and our proprietary 3ConneX Platform at the HONORABLE MENTION ... are excited to showcase our new Platinum and Gold ...
(Date:12/2/2016)... 2016 The iShares Nasdaq Biotechnology Exchange-Traded ... Trump,s victory early in November. Less political risk has ... now predicting an uptick in M&A activities. Today, Stock-Callers.com ... how they have fared at the last close: Celldex ... Inc. (NASDAQ: FOLD ), Navidea Biopharmaceuticals Inc. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... edition of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic ... health while maintaining fulfilling lives. “We are prolonging life 6 years in the ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering local frontline ... field of pain management. , The demand for supplemental training related to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the ... its unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition ... has been available in several ShopRite and FoodTown stores in NJ and received rave ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in ... fits into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started ... how the details line up exactly with Bible Prophecy – a protected way for ...
Breaking Medicine News(10 mins):